$PCRX
Pacira Biosciences Inc

2023 Q4 Form 10-Q Financial Statement

#000139681423000079 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $181.2M $163.9M
YoY Change 5.4% -2.11%
Cost Of Revenue $47.69M $39.75M
YoY Change -22.97% -21.56%
Gross Profit $133.6M $124.2M
YoY Change 21.37% 6.33%
Gross Profit Margin 73.69% 75.75%
Selling, General & Admin $65.80M $67.95M
YoY Change 2.86% 10.87%
% of Gross Profit 49.27% 54.72%
Research & Development $19.46M $20.83M
YoY Change 11.19% 7.34%
% of Gross Profit 14.57% 16.77%
Depreciation & Amortization $18.49M $4.100M
YoY Change -39.21% -29.31%
% of Gross Profit 13.84% 3.3%
Operating Expenses $99.59M $88.78M
YoY Change 3.96% 10.03%
Operating Profit $33.97M $17.72M
YoY Change 138.49% -16.76%
Interest Expense $37.00K $3.464M
YoY Change -100.45% -64.85%
% of Operating Profit 0.11% 19.55%
Other Income/Expense, Net $515.0K -$1.120M
YoY Change 535.8% -94.17%
Pretax Income $33.72M $16.60M
YoY Change -286.63% 702.37%
Income Tax $8.850M $5.743M
% Of Pretax Income 26.25% 34.59%
Net Earnings $24.87M $10.86M
YoY Change -346.19% -1666.81%
Net Earnings / Revenue 13.72% 6.62%
Basic Earnings Per Share $0.23
Diluted Earnings Per Share $0.36 $0.23
COMMON SHARES
Basic Shares Outstanding 46.44M shares 46.42M shares
Diluted Shares Outstanding 52.07M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $278.6M $235.2M
YoY Change -3.49% -28.45%
Cash & Equivalents $153.3M $99.12M
Short-Term Investments $125.3M $136.1M
Other Short-Term Assets $21.50M $18.60M
YoY Change 41.26% 29.02%
Inventory $104.4M $96.52M
Prepaid Expenses
Receivables $105.6M $96.96M
Other Receivables $0.00 $0.00
Total Short-Term Assets $510.0M $447.3M
YoY Change 2.34% -16.15%
LONG-TERM ASSETS
Property, Plant & Equipment $173.9M $175.8M
YoY Change -5.22% -9.22%
Goodwill $163.2M $163.2M
YoY Change -0.03% 3.68%
Intangibles $483.3M $497.6M
YoY Change -10.6% -14.36%
Long-Term Investments $38.46M $35.50M
YoY Change -40.26% -18.86%
Other Assets $144.5M $151.7M
YoY Change -9.87% -2.46%
Total Long-Term Assets $1.064B $1.087B
YoY Change -10.02% -9.47%
TOTAL ASSETS
Total Short-Term Assets $510.0M $447.3M
Total Long-Term Assets $1.064B $1.087B
Total Assets $1.574B $1.534B
YoY Change -6.35% -11.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.70M $16.51M
YoY Change 3.14% 27.67%
Accrued Expenses $64.24M $59.88M
YoY Change -28.45% -21.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.641M $8.600M
YoY Change -74.32% -74.61%
Total Short-Term Liabilities $97.38M $93.66M
YoY Change -34.1% -28.79%
LONG-TERM LIABILITIES
Long-Term Debt $513.8M $515.9M
YoY Change -21.66% -27.74%
Other Long-Term Liabilities $13.57M $11.95M
YoY Change 40.38% -37.5%
Total Long-Term Liabilities $13.57M $11.95M
YoY Change 40.38% -37.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $97.38M $93.66M
Total Long-Term Liabilities $13.57M $11.95M
Total Liabilities $704.3M $702.9M
YoY Change -22.28% -27.1%
SHAREHOLDERS EQUITY
Retained Earnings -$106.8M -$131.7M
YoY Change -28.2% -5.04%
Common Stock $46.00K $46.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $870.1M $831.6M
YoY Change
Total Liabilities & Shareholders Equity $1.574B $1.534B
YoY Change -6.35% -11.53%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $24.87M $10.86M
YoY Change -346.19% -1666.81%
Depreciation, Depletion And Amortization $18.49M $4.100M
YoY Change -39.21% -29.31%
Cash From Operating Activities $47.58M $44.50M
YoY Change 13.2% 4.33%
INVESTING ACTIVITIES
Capital Expenditures $1.798M $3.400M
YoY Change -67.26% -165.62%
Acquisitions
YoY Change
Other Investing Activities $10.17M -$1.000M
YoY Change -39.02% -97.64%
Cash From Investing Activities $8.374M -$4.300M
YoY Change -25.16% -90.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.779M -27.80M
YoY Change -96.96% 257.56%
NET CHANGE
Cash From Operating Activities 47.58M 44.50M
Cash From Investing Activities 8.374M -4.300M
Cash From Financing Activities -1.779M -27.80M
Net Change In Cash 54.18M 12.40M
YoY Change -1125.15% -198.12%
FREE CASH FLOW
Cash From Operating Activities $47.58M $44.50M
Capital Expenditures $1.798M $3.400M
Free Cash Flow $45.79M $41.10M
YoY Change 25.29% -14.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
0 usd
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
33648000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
93661000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
147774000 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
397976000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
404767000 usd
CY2023Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
117965000 usd
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
251056000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
57089000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64802000 usd
CY2023Q3 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
24275000 usd
CY2022Q4 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
28122000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11945000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9669000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
702911000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
906190000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-380000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
831551000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
775010000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1534462000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1681200000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163926000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
167466000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
39750000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
50678000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19405000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67947000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61283000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14322000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14322000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
146205000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
146177000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17721000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
21289000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2766000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1234000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
3464000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
9856000 usd
us-gaap Interest Expense
InterestExpense
16918000 usd
us-gaap Interest Expense
InterestExpense
28935000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-422000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10598000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19220000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16601000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2069000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5743000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2762000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45831000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10858000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
146000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-163000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
17000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
98000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
163000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11021000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-758000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
807975000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000 usd
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45927790 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45927790 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
963181000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
924095000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131666000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148751000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20830000 usd
CY2023Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-3356000 usd
CY2022Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-489000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1120000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-65000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12530000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
163000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10858000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
831551000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
756636000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1563000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12682000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-65000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
770123000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
775010000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1939000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
730408000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23498000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1821000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35415000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3040000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-837000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
770123000 usd
us-gaap Net Income Loss
NetIncomeLoss
17085000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9014000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2895000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57089000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
61095000 usd
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
2311000 usd
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
2957000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
728000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2107000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16926000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35475000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35415000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3847000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-23394000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
10000000 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
2415000 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
377000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1440000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2847000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
457000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1751000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6986000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
568000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1988000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4681000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-26156000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-23560000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
40000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
623000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107065000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103237000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13363000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24584000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
111682000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
319426000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
200970000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
152636000 usd
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
0 usd
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
32000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
69167000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1939000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23482000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1672000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1820000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
149550000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
5750000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1163000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-181252000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-343017000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5020000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-476154000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104139000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
585578000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99119000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109424000 usd
us-gaap Interest Paid Net
InterestPaidNet
24931000 usd
us-gaap Interest Paid Net
InterestPaidNet
23620000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2072000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4216000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3040000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1470000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5486000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
49196000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
39810000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
23765000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
28853000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23559000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27400000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
96520000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
96063000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
307157000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
300992000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
131374000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
117480000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175783000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183512000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
4100000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
5800000 usd
us-gaap Depreciation
Depreciation
14100000 usd
us-gaap Depreciation
Depreciation
18000000 usd
CY2023Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4000000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
3300000 usd
CY2023Q3 pcrx Number Of Leases
NumberOfLeases
2 lease
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3559000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3440000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10818000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10509000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
499000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
540000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1444000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1520000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
167000 usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
169000 usd
us-gaap Sublease Income
SubleaseIncome
489000 usd
us-gaap Sublease Income
SubleaseIncome
169000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
3891000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
3811000 usd
us-gaap Lease Cost
LeaseCost
11773000 usd
us-gaap Lease Cost
LeaseCost
11860000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
11055000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9922000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M3D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M9D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0703
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0695
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3249000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13038000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12775000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12814000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12587000 usd
CY2023Q3 pcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
27351000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
81814000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16100000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
65714000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
163200000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
163200000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
127376000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
462714000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
127376000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
497580000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
84410000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
505680000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
84410000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
540546000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
14300000 usd
CY2023Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period1
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
57300000 usd
CY2023Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period2
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
37400000 usd
CY2023Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period3
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3
7900000 usd
CY2023Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period4
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4
2200000 usd
pcrx Settlement Period Convertible Debt Conversion Request
SettlementPeriodConvertibleDebtConversionRequest
P40D
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3471000 usd
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
9343000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
16670000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
26724000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
683000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
903000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2311000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2956000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
25000 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
695000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
728000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2107000 usd
CY2023Q3 pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-715000 usd
CY2022Q3 pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-1085000 usd
pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-2791000 usd
pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-2852000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3464000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
9856000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
16918000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
28935000 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0298
CY2022Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0542
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0396
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0566
CY2023Q3 us-gaap Share Price
SharePrice
30.68
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
18259000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
13000000 usd
CY2022 pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
10000000 usd
CY2022 pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Gain Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
-67000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
21192000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
6758000 usd
pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Gain Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
-135000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
27815000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
136383000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
315000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
136069000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
222515000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
25000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
819000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
221721000 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
400000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
800000 usd
pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2022 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
200000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-300000 usd
CY2023Q2 pcrx Share Based Compensation Arrangement By Share Based Payment Award Increase In Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorized
3300000 shares
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12530000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12682000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35475000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35415000 usd
CY2023Q3 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
5957000 usd
CY2022Q3 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
6711000 usd
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
18163000 usd
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
20038000 usd
CY2023Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
6373000 usd
CY2022Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
5758000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
16592000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
14588000 usd
CY2023Q3 pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
200000 usd
CY2022Q3 pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
213000 usd
pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
720000 usd
pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
789000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12530000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12682000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35475000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35415000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6272994 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
52.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1435143 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
39.13
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
62680 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
30.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
195249 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
53.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
339565 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
53.15
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7110643 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
50634 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10858000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
us-gaap Net Income Loss
NetIncomeLoss
17085000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
11887000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-693000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
17085000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
29123000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46416000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45831000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46151000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45400000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52067000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46343000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52220000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8445000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13132000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12530000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3513000 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
16631000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9230000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
29047000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
39610000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-30000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-7161000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1066000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-8240000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16601000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2069000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27981000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31370000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5743000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2762000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10896000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5359000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.33
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.17
CY2023Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
0 usd
CY2022Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
194000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
0 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
4259000 usd
CY2023Q3 pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
390000 usd
CY2022Q3 pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
1532000 usd
pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
1588000 usd
pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
10162000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
173000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
1109000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-3356000 usd
CY2022Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-489000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
1150000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
13232000 usd
CY2023Q3 pcrx Litigation Settlement Amount Expected To Be Awarded From Other Party
LitigationSettlementAmountExpectedToBeAwardedFromOtherParty
14500000 usd
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001396814-23-000079-index-headers.html Edgar Link pending
0001396814-23-000079-index.html Edgar Link pending
0001396814-23-000079.txt Edgar Link pending
0001396814-23-000079-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcrx-20230930.htm Edgar Link pending
pcrx-20230930.xsd Edgar Link pending
pcrx-20230930_g1.jpg Edgar Link pending
pcrx-20230930_g2.jpg Edgar Link pending
pcrx-9302023xex311.htm Edgar Link pending
pcrx-9302023xex312.htm Edgar Link pending
pcrx-9302023xex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
pcrx-20230930_cal.xml Edgar Link unprocessable
pcrx-20230930_def.xml Edgar Link unprocessable
pcrx-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pcrx-20230930_pre.xml Edgar Link unprocessable
pcrx-20230930_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending